Breast health awareness campaign and screening pilot in a Kenyan County: Findings and lessons.


Journal

Cancer reports (Hoboken, N.J.)
ISSN: 2573-8348
Titre abrégé: Cancer Rep (Hoboken)
Pays: United States
ID NLM: 101747728

Informations de publication

Date de publication:
03 2022
Historique:
revised: 16 05 2021
received: 24 03 2021
accepted: 14 06 2021
pubmed: 9 7 2021
medline: 26 4 2022
entrez: 8 7 2021
Statut: ppublish

Résumé

Breast cancer is the leading cancer in terms of incidence in Kenya. We conducted a breast cancer awareness and screening pilot to assess feasibility of rolling out a national screening program in Kenya. Conducted in Nyeri County during October-November 2019, the pilot had three phases; awareness creation, screening (clinical breast examination and/or imaging) and final evaluation (post-screening exit interviews and retrospective screening data review). Descriptive statistics on awareness, screening process and outputs were derived. During the pilot, 1813 CBE, 217 breast ultrasounds and 600 mammograms were performed. Mammography equipment utilization increased from 11% to 83%. Of 49 women with suspicious lesions on mammography, only 22 (44.9%) had been linked to care 4 months after the campaign. Of 532 exit interview respondents; 95% (505/532) were ≥35 years of age; 80% (426/532) had been reached by the awareness campaign. Majority (75% [399/532]) had received information from community health volunteers; 68% through social groups. Majority (79% [420/532]) felt the campaign had changed their behavior on breast health. Although 77% (407/532) had knowledge on self breast examination (SBE); only 13% practiced monthly SBE. More than half (58% [306/532]) had previously undertaken a CBE. Approximately 70% (375/528) were unaware of mammography before the pilot; 86% (459/532) had never previously undertaken a mammogram. Fifty-five percent (293/532) of respondents had screening waiting times of >120 min. Community health workers can create breast cancer screening demand sustainably. Adequate personnel and effective follow-up are crucial before national roll-out of a breast cancer screening program.

Sections du résumé

BACKGROUND AND AIM
Breast cancer is the leading cancer in terms of incidence in Kenya. We conducted a breast cancer awareness and screening pilot to assess feasibility of rolling out a national screening program in Kenya.
METHODS
Conducted in Nyeri County during October-November 2019, the pilot had three phases; awareness creation, screening (clinical breast examination and/or imaging) and final evaluation (post-screening exit interviews and retrospective screening data review). Descriptive statistics on awareness, screening process and outputs were derived.
RESULTS
During the pilot, 1813 CBE, 217 breast ultrasounds and 600 mammograms were performed. Mammography equipment utilization increased from 11% to 83%. Of 49 women with suspicious lesions on mammography, only 22 (44.9%) had been linked to care 4 months after the campaign. Of 532 exit interview respondents; 95% (505/532) were ≥35 years of age; 80% (426/532) had been reached by the awareness campaign. Majority (75% [399/532]) had received information from community health volunteers; 68% through social groups. Majority (79% [420/532]) felt the campaign had changed their behavior on breast health. Although 77% (407/532) had knowledge on self breast examination (SBE); only 13% practiced monthly SBE. More than half (58% [306/532]) had previously undertaken a CBE. Approximately 70% (375/528) were unaware of mammography before the pilot; 86% (459/532) had never previously undertaken a mammogram. Fifty-five percent (293/532) of respondents had screening waiting times of >120 min.
CONCLUSION
Community health workers can create breast cancer screening demand sustainably. Adequate personnel and effective follow-up are crucial before national roll-out of a breast cancer screening program.

Identifiants

pubmed: 34235881
doi: 10.1002/cnr2.1480
pmc: PMC8955074
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1480

Informations de copyright

© 2021 The Authors. Cancer Reports published by Wiley Periodicals LLC.

Références

World J Surg. 2010 Sep;34(9):2204-10
pubmed: 20533039
Cancer Causes Control. 2017 Nov;28(11):1207-1218
pubmed: 28685277
Asian Pac J Cancer Prev. 2015;16(15):6285-8
pubmed: 26434830
J Glob Oncol. 2019 Jul;5:1-11
pubmed: 31291138
Cancer Rep (Hoboken). 2022 Mar;5(3):e1480
pubmed: 34235881
J Womens Health (Larchmt). 2017 Oct;26(10):1094-1098
pubmed: 28157432
PLoS One. 2019 Nov 1;14(11):e0224667
pubmed: 31675357
Breast J. 2016 May;22(3):330-4
pubmed: 27191360
J Cancer Educ. 2017 Mar;32(1):16-23
pubmed: 26373418
BMC Public Health. 2019 Feb 18;19(1):204
pubmed: 30777038
Health Policy. 2018 Nov;122(11):1198-1205
pubmed: 30195444
Int J Cancer. 2018 Dec 15;143(12):3273-3280
pubmed: 30006933
J Glob Oncol. 2018 Sep;4:1-7
pubmed: 30241140
J Community Health. 2018 Aug;43(4):633-638
pubmed: 29280089
Health Policy. 2018 Apr;122(4):422-430
pubmed: 29454541
Cancer Causes Control. 2017 Feb;28(2):137-143
pubmed: 28097471
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
BMC Public Health. 2019 Feb 12;19(1):180
pubmed: 30755192
BMJ Open. 2020 Aug 20;10(8):e036503
pubmed: 32819988

Auteurs

Valerian Mwenda (V)

National Cancer Control Program, Ministry of Health, Nairobi, Kenya.

Joan-Paula Bor (JP)

National Cancer Control Program, Ministry of Health, Nairobi, Kenya.

Hannah Gitungo (H)

National Cancer Control Program, Ministry of Health, Nairobi, Kenya.

Lydia Kirika (L)

National Cancer Control Program, Ministry of Health, Nairobi, Kenya.

Richard Njoroge (R)

National Cancer Control Program, Ministry of Health, Nairobi, Kenya.

Beatrice Mugi (B)

Radiology and Diagnostic Imaging Department, Kenyatta National Hospital, Nairobi, Kenya.

Daniel Ojuka (D)

Department of Surgery, University of Nairobi, Nairobi, Kenya.

Mary Nyangasi (M)

National Cancer Control Program, Ministry of Health, Nairobi, Kenya.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH